Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Pacific Biosciences of California Inc (NASDAQ: PACB) closed at $1.77 in the last session, down -4.32% from day before closing price of $1.85. In other words, the price has decreased by -$4.32 from its previous closing price. On the day, 5.94 million shares were traded. PACB stock price reached its highest trading level at $1.835 during the session, while it also had its lowest trading level at $1.74.
Ratios:
We take a closer look at PACB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.64 and its Current Ratio is at 9.74. In the meantime, Its Debt-to-Equity ratio is 2.03 whereas as Long-Term Debt/Eq ratio is at 2.01.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 30 ’24 when Kim Susan G. sold 19,782 shares for $1.72 per share. The transaction valued at 34,065 led to the insider holds 695,654 shares of the business.
SUSAN KIM bought 19,782 shares of PACB for $34,061 on Sep 30 ’24. On Sep 16 ’24, another insider, HENRY CHRISTIAN O, who serves as the insider of the company, sold 98,907 shares for $1.75 each. As a result, the insider received 172,692 and left with 2,497,763 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PACB now has a Market Capitalization of 520937568 and an Enterprise Value of 956252544. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.80 while its Price-to-Book (P/B) ratio in mrq is 1.07. Its current Enterprise Value per Revenue stands at 5.523 whereas that against EBITDA is -3.937.
Stock Price History:
Over the past 52 weeks, PACB has reached a high of $10.65, while it has fallen to a 52-week low of $1.16. The 50-Day Moving Average of the stock is -7.41%, while the 200-Day Moving Average is calculated to be -23.15%.
Shares Statistics:
According to the various share statistics, PACB traded on average about 9.50M shares per day over the past 3-months and 11840480 shares per day over the past 10 days. A total of 267.74M shares are outstanding, with a floating share count of 262.20M. Insiders hold about 4.26% of the company’s shares, while institutions hold 81.80% stake in the company. Shares short for PACB as of 1730332800 were 50406598 with a Short Ratio of 5.30, compared to 1727654400 on 51642651. Therefore, it implies a Short% of Shares Outstanding of 50406598 and a Short% of Float of 21.3.